Regen BioPharma Inc (RGBP)

[art35]

Regen BioPharma Inc (OTCMKTS: RGBP)

Is the new darling of small caps currently making a parabolic run up the charts and quickly establishing itself as a top traded stock in small caps.

Currently under heavy accumulation RGBP traded $50 million in dollar volume on Thursday alone on 3.5 billion shares traded and is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension –

Tesoro went to multi dollars. RGBP is in beast mode right now and is the most talked about small cap stock; a break over $0.0295 and things really start popping here.

Regen and its subsidiary KLS have entered into an agreement with Oncology Pharma, Inc. whereby Regen granted to Licensee an exclusive right and license for the development and commercialization of certain intellectual property for the treatment in humans of pancreatic cancer for a term of fifteen years from April 7, 2021.

The License IP consists of antigen specific cancer vaccines in which modified mRNA is administered to produce epitopes able to produce an immune response which augments likelihood of successful induction of immunity.

An epitope is the part of an antigen that is recognized by the immune system.

The Company is currently in the process of updating its filings and preparing outstanding 10Q and 10k reports in order to up list to fully reporting otcqb “pink current” tier

Cheers